Literature DB >> 31469328

Phosphonate prodrugs: an overview and recent advances.

Kenneth M Heidel1, Cynthia S Dowd1.   

Abstract

Phosphonates, often used as isosteric replacements for phosphates, can provide important interactions with an enzyme. Due to their high charge at physiological pH, however, permeation into cells can be a challenge. Protecting phosphonates as prodrugs has shown promise in drug delivery. Thus, a variety of structures and cleavage/activation mechanisms exist, enabling release of the active compound. This review describes the structural diversity of these pro-moieties, relevant cleavage mechanisms and recent advances in the design of phosphonate prodrugs.

Entities:  

Keywords:  drug discovery; medicinal chemistry; phosphonate; prodrug activation; prodrugs

Mesh:

Substances:

Year:  2019        PMID: 31469328      PMCID: PMC6722485          DOI: 10.4155/fmc-2018-0591

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  132 in total

1.  Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA.

Authors:  C Ballatore; C McGuigan; E De Clercq; J Balzarini
Journal:  Bioorg Med Chem Lett       Date:  2001-04-23       Impact factor: 2.823

2.  Degradation kinetics of oxycarbonyloxymethyl prodrugs of phosphonates in solution.

Authors:  L C Yuan; T C Dahl; R Oliyai
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

3.  Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.

Authors:  A Reichenberg; J Wiesner; C Weidemeyer; E Dreiseidler; S Sanderbrand; B Altincicek; E Beck; M Schlitzer; H Jomaa
Journal:  Bioorg Med Chem Lett       Date:  2001-03-26       Impact factor: 2.823

4.  Evaluation of the mutagenic and genotoxic activities of anti-hepatitis B analogs of beta-L-adenosine by the Ames test and the Comet assay.

Authors:  L Placidi; M De Meo; G Gosselin; J L Imbach; M L Bryant; G Dumenil; J P Sommadossi
Journal:  Antiviral Res       Date:  2001-05       Impact factor: 5.970

Review 5.  Pivalate-generating prodrugs and carnitine homeostasis in man.

Authors:  Eric P Brass
Journal:  Pharmacol Rev       Date:  2002-12       Impact factor: 25.468

6.  Bisphosphonate prodrugs: synthesis and in vitro evaluation of alkyl and acyloxymethyl esters of etidronic acid as bioreversible prodrugs of etidronate.

Authors:  R Niemi; P Turhanen; J Vepsäläinen; H Taipale; T Järvinen
Journal:  Eur J Pharm Sci       Date:  2000-08       Impact factor: 4.384

7.  Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.

Authors:  Earl R Kern; Caroll Hartline; Emma Harden; Kathy Keith; Natalie Rodriguez; James R Beadle; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

8.  Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

Authors:  Patrick Marcellin; Ting-Tsung Chang; Seng Gee Lim; Myron J Tong; William Sievert; Mitchell L Shiffman; Lennox Jeffers; Zachary Goodman; Michael S Wulfsohn; Shelly Xiong; John Fry; Carol L Brosgart
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

9.  Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.

Authors:  Kathy A Aldern; Stephanie L Ciesla; Kristine L Winegarden; Karl Y Hostetler
Journal:  Mol Pharmacol       Date:  2003-03       Impact factor: 4.436

10.  Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.

Authors:  James R Beadle; Caroll Hartline; Kathy A Aldern; Natalie Rodriguez; Emma Harden; Earl R Kern; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more
  6 in total

1.  Halogen-Dance-Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2-Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases.

Authors:  Michal Česnek; Michal Šafránek; Martin Dračínský; Eva Tloušťová; Helena Mertlíková-Kaiserová; Michael P Hayes; Val J Watts; Zlatko Janeba
Journal:  ChemMedChem       Date:  2021-10-22       Impact factor: 3.466

2.  Phosphoryl Prodrugs: Characteristics to Improve Drug Development.

Authors:  Samuel A Kirby; Cynthia S Dowd
Journal:  Med Chem Res       Date:  2021-07-23       Impact factor: 2.351

3.  A mild and concise synthesis of aryloxy phosphoramidate prodrug of alcohols via transesterification reaction.

Authors:  Hanglu Ying; Jie Yao; Fan Wu; Yufen Zhao; Feng Ni
Journal:  RSC Adv       Date:  2022-04-29       Impact factor: 4.036

Review 4.  Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.

Authors:  Marcela Krečmerová; Pavel Majer; Rana Rais; Barbara S Slusher
Journal:  Front Chem       Date:  2022-05-20       Impact factor: 5.545

5.  Incorporation of a FRET pair within a phosphonate diester.

Authors:  Nyema M Harmon; Xueting Huang; Chia-Hung Christine Hsiao; Andrew J Wiemer; David F Wiemer
Journal:  Bioorg Chem       Date:  2021-05-30       Impact factor: 5.307

6.  Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia.

Authors:  Srabani Kar; Madhusoodanan Mottamal; Rami A Al-Horani
Journal:  ChemistryOpen       Date:  2020-11-10       Impact factor: 2.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.